Mark Zinn

Mark Zinn, PhD is a specialist in autonomic neuroscience, conducting ME/CFS studies with his wife, Marcie Zinn Ph.D. in their nonprofit entity, the NeuroCognitive Research Institute. Mark was part of the Chronic Fatigue Syndrome Initiative at Stanford between 2011 and 2014, working with Dr. Jose Montoya. Mark continues to collaborate with the ME/CFS Initiative at Stanford Medicine. Mark Zinn was one of the 42 signatories of the Open Letter to the Lancet calling for the PACE trial data to be independently reanalysed.

Notable studies

 * Mar 2014 - Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA (Abstract - full text on request)
 * 2015 - Myalgic Encephalomyelitis: Symptoms and Biomarkers (Full Text)
 * 2016 - Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study (Full Text)
 * 2016 - qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report (Full Text)
 * 2016 - Functional Neural Network Connectivity in Myalgic Encephalomyelitis (Full Text)
 * 2017, Small-world network analysis of cortical connectivity in Chronic Fatigue Syndrome using quantitative EEG. (Full Text)
 * 2018 - Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome (Abstract)
 * 2019 - The Central Autonomic Network in Myalgic Encephalomyelitis Syndrome / Chronic Fatigue Syndrome, Doctoral Dissertation.

Online presence

 * website, https//:www.thencri.org
 * LinkedIn
 * theNCRI (facebook)
 * theNCRI (twitter)